“Innovation in Palatable and Species-Specific Formulations”
- A significant and accelerating trend in the EMEA solid oral veterinary excipients market is the shift toward palatable and species-specific formulation development, aimed at improving treatment adherence among both companion and livestock animals. This trend is being driven by rising demand for veterinary drugs that are easier to administer and more effective in achieving desired therapeutic outcomes
- For instance, manufacturers such as DFE Pharma and Roquette are actively developing taste-masking and flavor-enhancing excipients, including sweeteners and natural flavors, to improve palatability in chewable tablets and powders. These advances are tailored to different species’ preferences, ensuring more successful administration
- Functional excipients are also being optimized to support enhanced drug stability, controlled release, and bioavailability across varied animal gastrointestinal systems. For instance, multi-functional binders and coating agents are being utilized to achieve precise drug delivery in monogastric and ruminant species
- The integration of these excipients into solid oral dosage forms supports better disease management, especially in high-value pets and production animals, where consistent dosing and compliance are critical
- This trend is further bolstered by stringent European regulations emphasizing safety, quality, and animal welfare, encouraging innovation in excipient design that aligns with both regulatory and therapeutic expectations
- The push toward more animal-friendly, high-performance excipient solutions is reshaping veterinary drug formulation practices across EMEA, offering new value propositions for manufacturers and improving outcomes in veterinary healthcare
